Cognitive comorbidities are very common in epilepsy and often seen as secondary to epilepsy or caused by epilepsy. The implicit and sometimes explicit assumption is that epilepsy (i.e. having seizures) damages the brain and thus leads to functional deterioration and behavioral alterations. This article highlights the historical background surrounding this viewpoint which is characterized by old reports on 'epileptic dementia' and the fact that most cognitive research in chronic epilepsies is done retrospectively. The central question of the present article is whether there is a bidirectional relationship between epilepsy and cognition. In this regard it is essential to disentangle what is the disease and what is the symptom. Cognitive problems often exist from the onset of epilepsy, if not before, and the impact of epilepsy on cognition cannot be discerned without also considering the underlying brain pathology and its dynamics. Unraveling the etiologies of epilepsy increasingly reveals conditions wherein epilepsy, cognitive and behavioral problems are all symptoms of a common underlying pathological condition. Functional reserve capacities determine the outcome of epilepsy and its treatment. A functional interrelationship exists between epilepsy and behavior, since epileptic activity can affect behavior and behavior can alter epileptic activity. In conclusion, an epilepsy-centric unidirectional view of the behavioral problems being caused by epilepsy is obsolete. Such a view may even prevent the search for and treatment of the underlying etiological factors. Instead a practical clinical approach is favored according to which the comorbidities of epilepsy must be diagnosed at the onset of the disease, and according to which comorbidities may require separate treatment approaches.
Introduction
Cognitive impairments, as well as mood and behavioral problems, represent very common comorbidities of epilepsy. In chronic epilepsies, cognitive deficits are observed in about 70-80% of patients, and a depressed mood can be seen in up to 60% [1, 2] . It is generally accepted that cognition in epilepsy is multifactorially determined by structural brain lesions, the active epilepsy, its treatment, and individual reserve capacities [3, 4] . Whereas ictal and postictal cognitive dysfunction is reversible [5] , a commonly held position is that with the accumulation of lifetime seizures a progressive mental decline is present in chronic and uncontrolled epilepsy. However, an index disease such as epilepsy and its comorbid conditions (e.g. depressed mood, memory deficits) can but must not be interrelated [6] . The term comorbidity neither implies nor excludes a causal association. Nevertheless, epileptology leans towards a relatively epilepsy-centric view in which the active epilepsy with recurrent seizures is either implicitly or overtly understood as the major origin of the mental and behavioral problems seen with epilepsy. This suggests that the problems should be resolved when the seizures are successfully treated. The epilepsy-centric view, however, has recently been challenged by observations that: a) comorbidities determine the outcomes of epilepsies [7] ; b) comorbidities often precede the onset of epilepsy; and c) conditions exist wherein both epilepsy and the accompanying behavioral comorbidities must be considered as symptoms or expressions of a common underlying pathology [8] .
Historically, the idea that epilepsy causes progressive cognitive decline dates back to the term "epileptic dementia" which was coined at the turn of the 19th century. The German psychiatrist Emil W. G. M. Kraepelin [9] and subsequently the German psychiatrist and neurologist Oswald Bumke [10] wrote about epileptic dementia and the epileptic character. Kraepelin stated that a pronounced, strange sort of dementia appears in more than 50% of the patients with epilepsy which is characterized by generalized slowness and clumsiness of all psychic capabilities ("In mehr als der Hälfte der Fälle, die dem Irrenarzt zu Gesicht kommen, findet sich ein mehr oder weniger ausgeprägter, eigenartiger Schwachsinn" 1 p. 456, [9] ). Interestingly, it was suggested that the prevalence would even be higher after excluding all the "simple" symptomatic cases and those cases with so-called residual epilepsy. For example, it was a commonly held belief that tumors were an insufficient cause for explaining the characteristic dementia in epilepsy. The same assumption was held for what has been called the epileptic personality which was characterized by irritability, viciousness, hopelessness, religious ideation, subservience, and stilted courtesy. Thus, the neuropsychiatrists of that time suggested that a "pure" or "genuine epilepsy" causes mental decline and personality change. Although the negative behavioral side-effects of the drug bromide were well known (sleepiness, drowsiness, memory problems), and although transient and reversible postictal impairments were well recognized, it was also noted that frequent seizures can cause permanent intellectual deficits [10] . However, the question remains as to whether these problems occur together or whether one phenomenon depends upon the other. Another source of the assumed unidirectional determination of cognitive impairments caused by epilepsy can be seen in a research bias. The vast majority of neuropsychological studies on epilepsy concern long-standing chronic epilepsies. This is because neuropsychology and the related research are predominantly performed within the context of epilepsy surgery and pharmacological trials (mostly add-on studies). In long-standing epilepsies, it is hardly possible to retrospectively discern the origin, development and determinants of actual cognitive deficits, thus leaving one with retrospective speculations rather than prospective evidence. A common finding of retrospective studies in chronic patients with epilepsy is that the longer the duration of epilepsy, the worse the cognition [11] .
Finally, animal models of epilepsy have contributed to the presumption that seizures damage the brain. In this area, there is clear evidence highlighting the negative effect of epilepsy and seizures on brain structure and behavior [12] , but the question remains as to whether this can easily be transferred to man [13] .
Thus, the notion of recurrent seizures as the leading cause of behavioral change and mental decline in epilepsy is a commonly held notion throughout the world, but the question is whether this position really holds true when closely examining the scientific literature. The causal relationship between epilepsy and its behavioral comorbidities was first challenged in epidemiological studies showing that psychiatric comorbidities may well precede the onset of epilepsy [14, 15] and that they may even be viewed as a biomarker for developing epilepsy. However, it should be noted that similar considerations can be found with regard to dementia and its comorbidities as it is understood that depression, mild cognitive impairment and even subjective memory impairment are biomarkers or first hints of who is at risk for developing dementia [16, 17] .
This article also seeks to address the etiologies of cognitive and behavioral problems in epilepsy and the sequence of their occurrence during the course of the disease. We will question the notion of a causal relationship between epilepsy and cognitive impairment and discuss the conditions under which epilepsy (i.e. having seizures) must be perceived as a symptom rather than as a disease. Finally, we will address the impact of epileptic activity and seizures on cognition and, conversely, the impact of cognition on epileptic activity and seizures.
Untangling the etiologies of cognitive and behavioral problems in epilepsy
Cognitive and behavioral problems in epilepsy must be seen within a multifactorial and neurodevelopmental model which, apart from demographic patient characteristics and the type of epilepsy, takes into account the structural morphological aspects, seizures, interictal epileptic activity, treatments, psychiatric comorbidites, and individual reserve capacities. Thus, cognitive problems in epilepsy can have multiple causes which, when viewed individually or in combination, determine the course of cognitive development and, when taken as symptoms, are not disease-specific [3] .
The same holds true for behavioral problems. Depression can be caused by different factors: a) it may be primarily reactive due to conflicts or problems that might be related to having epilepsy; b) it may be induced by antiepileptic medication; c) it could be due to structural damage or epileptic disturbances in networks subserving emotional processing; or d) it may be the result of a common underlying pathology or the combination of one or more of these factors [18, 19] . Different from cognitive problems, depression, however, is usually considered a disease. In epilepsy, it may also be seen as a symptom.
For patients with longstanding epilepsy, untangling the source of an observed cognitive dysfunction can be challenging. If a patient with focal cortical dysplasia and chronic frontal lobe epilepsy, who is also depressed, is treated with a combination of three antiepileptic drugs, including one which is known to affect executive functions, and if the neuropsychological evaluation reveals a low IQ and impaired executive functions, several factors converge which may explain the impairments. The executive deficit may be caused a number of factors: a) the underlying lesion and/or its neuro-developmental effects; b) the active epilepsy (i.e. seizures and interictal epileptic activity); c) the total drug load; d) drug-drug interactions; e) any specific pharmacological agent; or f) the lack of drive and motivation due to depression. On an individual level, the relative contribution of the various etiological factors can be evaluated only longitudinally with repeated standardized assessments along with a reduction of the drug load, exchange of the individual drugs, achievement of seizure freedom, or after the successful treatment of the depressive symptomatology.
On a group level, with well-defined and matched control groups, one can easily differentiate and quantify the differential impact of the active epilepsy, the total drug load and the antiepileptic treatment with an individual substance on cognition [20] .
Within a multifactorial model of cognitive and behavioral problems in epilepsy, it is also important to consider the potential beneficial effects of the antiepileptic therapy on cognition via drug inherent effects, positive effects on mood, and seizure control [21] [22] [23] , as well as neurodevelopmental aspects such as neuronal plasticity and mental reserve capacities [4] .
The impact of chronic epilepsy on cognition
As already stated, the idea that epilepsy damages the brain and thus leads to a progressive mental decline is mostly supported by cross-sectional studies focusing on the relation between cognition and the duration of epilepsy. The respective finding is that the longer the duration of epilepsy, the poorer the cognitive status. This has been demonstrated in particular with regard to the intelligence of patients with temporal lobe epilepsy and was interpreted as being caused by an accumulation of noxae and damages along with the uncontrolled epilepsy. However, the suggested decline appears slow with a change of more than one standard deviation over a time period of about 30 years [11] . Crosssectional studies generally disclose the methodological problem which states that in chronic epilepsy, a long duration of epilepsy is highly confounded with an earlier onset and/or an older age. Thus, the low IQ score in a patient with a long-standing epilepsy can be due to: a) the chronic epilepsy and the negative cumulative effect of seizures; b) an initial impairment and its negative effects on mental development; or c) an initial impairment interacting with normal ageing. Again, a condition in which combinations of these aspects contribute to the observed clinical picture at a certain time point must also be considered. An interesting observation concerning the lower IQ score with a longer epilepsy duration is that the same relationship applies to education (i.e. the longer the epilepsy, the less educated the patients). While intelligence may be lost over time, a loss in education and degrees is not possible [24] . Therefore, this finding would imply that interference of early onset epilepsy is associated with developmental cognitive problems hindering acquisition of knowledge and skills rather than with a mental decline in terms of a loss of previously acquired functions.
Another way to infer the impact of chronic epilepsy on cognition with a cross-sectional study design is to compare agerelated regressions of cognition in patients against age-related regressions observed in healthy controls. The comparison of patients and healthy subjects at any given age should reveal the time points of different mental trajectories. Interestingly, such a procedure does not support the assumption of accelerated mental decline with a longer duration of epilepsy, but rather shows that impairments are established early on, that they hinder mental development, and that their course over time is quite stable, running parallel to, but at a significant lower level than, cognitive ageing in healthy people [25, 26] .
Apart from cross-sectional studies, there is also information on cognitive development from several longitudinal studies in medically and surgically treated patients with epilepsy. Whereas the age range of cross-sectional studies can cover a lifetime, the observational periods of longitudinal studies mostly span 10 years at best [27] [28] [29] [30] [31] . The longest longitudinal evaluation of a single patient had a follow-up period of 56 years after surgical treatment of a left temporal lobe epilepsy [32] . In this patient, a cognitive decline from early postsurgical assessments to the long-term follow-up at 82 years of age was restricted to functions associated with the resection site (i.e. verbal memory and language functions) without any debilitating effect on daily functioning. The longest follow-up (50 years) in a cohort of children with idiopathic symptomatic and cryptogenic epilepsies has been published by Sillanpää et al. in 2015 [33] , but this study did not take cognition into account. However, the fact that many patients (61%) were in terminal remission and in remission being off medications (43%) contradicts the often assumed detrimental effects of chronic epilepsies. Whether there is cognitive recovery with remission and tempering of drug treatment would be of major interest.
Even when taking into account the restriction of limited observation intervals, longitudinal group studies still provide evidence of at least some decline. Deterioration, however, does not appear to be the rule. Determinants of a negative trend are active seizures and generalized tonic-clonic seizures in particular, traumatic brain injury, structural epilepsy, as well as drug therapy and a poorer baseline performance [27] [28] [29] [30] 34, 35] . These factors are markers for more severe epilepsies as well as for reduced mental reserve capacities for compensation. The observations with regard to cognitive trajectories are consistent with cross-sectional and longitudinal MRI studies which address the question of structural alterations over time, with some studies revealing a volume loss while others do not display any change [36] .
Postoperative studies which permit the study of the cognition course in controlled epilepsies show that after initial losses due to surgery, the long-term follow-up indicates a rather stable course, if not an improvement due to seizure control and the reduced antiepileptic drug load [30, [37] [38] [39] [40] .
Up to this point, epilepsies having a clear negative dynamic with progression of the epilepsy and cognitive decline have not yet been addressed. For these so-called epileptic encephalopathies, an effect of the epilepsy on cognition beyond the underlying pathology is often proposed, however no common seizuredependent mechanism for epilepsy progression or intellectual deterioration can be discerned [41] . Of special interest is the effect of status epilepticus on cognition. It is the worst seizure scenario and thus a kind of proof-of-principle. Studies which have evaluated cognitive change over time in patients who experienced a status within the observation interval (versus those who have not) interestingly found either no changes or only minor changes [5, 16, 42, 43] . One major finding was that patients with a status showed poorer cognition already at baseline. This would be consistent with the cross-sectional observation in patients with convulsive or non-convulsive status epilepticus; these groups had a lower IQ and less education when compared to those patients without a status in their history. This indicates that it is more likely that a more severely damaged brain develops a status than the theory stating that a status damages the brain [44] . This does not imply that no clinical conditions exist whereby the underlying pathology, of which the status is an expression, can lead to mental deterioration and permanent damage [44] . Also, secondary damage due to hypoxia or traumatic brain injuries due to severe falls may cause irreversible cognitive deterioration. One can also argue that excitotoxicity due to excitatory over-activation during status epilepticus can cause irreversible neuronal cell loss [45] . However, lack of a clear-cut neuropsychological deterioration after an epileptic status solely due to the ictal epileptic discharges puts the clinical relevance of the epileptic activity into perspective.
Other than the underlying pathology, no clear evidence currently exists which states that epileptic activity and seizure occurrence alone can cause a significant mental decline or a permanent irreversible cognitive impairment in chronic epilepsies. It seems more likely that the time prior to and around epilepsy onset is of much greater importance with regard to the origin of the cognitive impairment than previously assumed. Accordingly, it is essential to examine cognition at the time of epilepsy onset in order to understand when the problems occur and what effects the course of the disease and its treatment will have on cognition.
Cognition in new-onset epilepsy
Thanks to the existence of routine neuro-and social-pediatric services, the close observation of children in kindergarten and school, and parental concerns and efforts, most children with newonset epilepsy are closely monitored with regard to their mental status and brain development. When taking all of this into account, it is difficult to comprehend why it took so many years for neuropsychologists to direct their focus to the onset of epilepsy in adults. Possible reasons (i.e. research bias) have already been mentioned. Another explanation is that neuropsychology in newonset epilepsies for the adult population is not as yet considered a routine assessment and not paid for. Finally, there seems to be scarce and insufficient communication between adults and pediatric neurologists, which is mostly due to a lack of transition from children to adult patient care [46] . No one would doubt that cognitive and behavioral problems in children very often exist from the beginning of epilepsy and that the trajectories of cognition afterwards depend on the pathology, disease dynamics, positive/ negative treatment effects, and seizure control [47, 48] .
A recent review on cognition at the time of adult and late onset epilepsies revealed what one would expect [49] . Cognitive impairment is very often already present at the time of epilepsy onset. The review summarized 11 studies on untreated adult, newly diagnosed or new-onset epilepsies. Up to 70% of the more than 500 patients with new-onset and not yet treated epilepsies, assessed in three of the included studies, displayed some cognitive deficit when formally tested with psychometric tests on attention, executive functions, and memory [49] [50] [51] . Predictors of the presence and severity of impairment include education (protective), etiology of the epilepsy, and the presence of generalized tonic-clonic seizures. Consequently, cognitive screening in newonset epilepsies should become a routine assessment, also for the adult population [51, 52] . Information concerning the patient's cognitive status at the onset of epilepsy and prior to the initial treatment enables the physician to monitor the course of the disease and to attribute the potential changes which may occur to either the treatment's success or failure, AED side effects, and the dynamics of the underlying pathology. The inclusion of multiple epilepsy centers with large cohorts of patients would permit identification of epilepsy subgroups, responders vs. non-responders and the ability to identify suitable candidates for surgical or other non-pharmacological treatments early in the course of the disease [8] .
Follow-up evaluations of newly diagnosed or new-onset and first treated epilepsies provide divergent findings. Two follow-up studies of newly diagnosed patients which were part of the SANAD (Standard and New Antiepileptic Drug) study provided evidence of a principally stable course, but of worsened functions as well [53, 54] . A closer look at the variables which changed reveals that after correcting for multiple testing, the most robust changes were seen with regard to attention, psychomotor speed and executive functions. These functions, however, belong to those most sensitive to drug treatment and seizure control [55, 56] , and there is additional evidence from a large monotherapy study in patients with new-onset epilepsy that the cognitive outcome can as well vary as a function of the administered antiepileptic drug [21] .
Thus, deficits are often present when epilepsy begins, and their temporal progress seems to depend on the etiology, positive/ negative treatment effects, and treatment success.
Is cognitive dysfunction a risk factor for developing epilepsy?
Prior to the epilepsy onset (e.g. the first unprovoked seizure(s)), acquired, congenital, or developmental cerebral lesions, covert epileptic dysfunction, and behavioral/psychiatric problems can have a negative impact on cognition [49] . Accordingly, just on the basis of theoretical considerations, one can expect cognitive problems to already be present before epilepsy onset. Depending on their etiology, cognitive deficits can be permanent. They may also increase due to developmental hindrance or progress of the underlying pathology or they may be reversible, if the treatment of the underlying disease or seizures is successful. The fact that cognitive impairment often is already present when an epilepsy starts, however, does not answer the question as to whether cognitive dysfunction is a risk factor for the developing epilepsy. We are not aware of any studies that explicitly address this issue but once again, this question can be approached theoretically. Both cognitive impairments and seizures represent symptoms of altered brain function, and it is not surprising that the probability of seizure occurrence is increased in the presence of a pathology which also causes cognitive problems. This does not mean that cognitive dysfunction is a necessary or sufficient criterion for developing epilepsy.
One can, however, argue that poorer cognitive functions are an indicator of less cognitive differentiation, and thus less inhibitory capacities, leading to an increased probability of seizure occurrence and spread. Better cognition is generally understood as a marker of greater reserve capacity to cope with any harming condition, be it transitory or permanent. Better cognition, as expressed by IQ for example, has repeatedly been demonstrated as an indicator for treatment success [57] [58] [59] [60] [61] .
Epileptic dysfunction and cognition are in part strongly connected to each other; they may occur together due to a common underlying pathological process, but they may also be related in a bidirectional way. Cognition can be negatively affected by epileptic activity as it is discussed with the concept of TCI (transient cognitive impairment) when cognition is corrupted during the presence of epileptic EEG activity (i.e. single or groups of spikes or spike waves, or longer phases of epileptic activity in terms of nonconvulsive seizures) [62] [63] [64] [65] . The occurrence of seizures not only depends on the activity of the epileptic focus but also on the activity of distant non-pathological brain areas [66] . Consequently, if non-focal brain areas are under intentional use cognitive activation can hinder seizure evolution, because it becomes difficult for epilepsy to overtake/recruit the brain areas which are already functionally occupied. Techniques of behavioral seizure control techniques are mostly based on this principle [67] [68] [69] . Unfortunately this relation is not one-way and linear, i.e. cognition opposes epilepsy. It rather seems to follow a U-shaped function in terms of an optimal network favoring seizure generation and spread. In fact sometimes cognitive activation of epilepsy-related networks can trigger seizures [70] as it is observed particularly in reflex epilepsies [71] .
When seizures as well as cognitive and mood problems represent symptoms
As described in the introduction section, epileptology tends to have an epilepsy-centric view regarding epilepsy as the implicit causal factor of cognitive and behavioral comorbidities. Physicians from different disciplines could well argue that epilepsy represents a secondary condition induced by head trauma, tumor, depression, etc. as dependent on which medical condition is taken as the index disease. Here, it is argued that the term comorbidity of epilepsy, as long as any causal direction is implicated, is problematic, since it prevents the unbiased view of the disease and may even prevent the search for causal factors. The decisive question is when and under which conditions epilepsy (i.e. having seizures) is a disease or a symptom, thus leading back to the initial discussion of the beginnings of epileptology, wherein about 82% of the cases of pure or genuine epilepsy was assumed to represent the majority of epilepsies [9, 10, 72] . This would be viewed in a totally different manner today. In the 1990s, about 30% of the epilepsies of the Icelandic population had an identifiable etiology [73] . From studies in patients with temporal lobe epilepsy, we know that with improved neuroimaging and with subsequent evaluations by experts and quantitative analyses, the number of non-lesional cases is fading away [74, 75] . Thus, our knowledge is increasing with regard to the etiologies of epilepsies, which finds its expression in ever-changing terminology and classification systems. These tend to move away from a symptom-and syndromebased description of epilepsies and seizures, and towards the inclusion of etiologies which also includes genetic causes [76] . The most recent insights into the relation of epilepsy and its behavioral "comorbidities" come from the recognition of an increasing number of late-onset temporal lobe epilepsies on the basis of autoimmunological inflammatory processes. In an epileptological context, autoimmune encephalitis often presents with seizures of a mesio-temporal origin, corresponding MRI changes (hippocampal and/or amygdala swelling and FLAIR hyperintensity), as well as cognitive and psychiatric symptoms which can be acute, but are more often subacute and waxing and waning [77] [78] [79] . Subgroups of limbic encephalitis can be discerned with auto-antibodies directed against neuronal cell surface antigens, or intracellular neuronal antigens as well as auto-antibody negative patients who are thought to suffer from limbic encephalitis as they share clinical features with antibody positive patients. Three aspects of limbic encephalitis are relevant for the purpose of this paper. First, limbic encephalitis can lead to temporal lobe epilepsy with hippocampal atrophy and sclerosis. As seen in patients with antibodies against the voltage-gated potassium channel (VGKC), the antibodies, seizures, MRI abnormalities, cognition, and psychiatric symptoms can co-vary during the course of the disease and with treatment success. If treated successfully with immunomodulatory therapy, the seizures disappear and both cognition and mood improve [80] [81] [82] [83] . Residual problems are possibly dependent on the affected molecular target [80] and how early treatment is initiated (i.e. whether permanent structural damage could be prevented). Therefore, one obtains insight into the evolution of mesial temporal lobe epilepsy with hippocampal sclerosis, and what is more important, one can clearly state that in this condition, seizures, cognitive problems, and psychiatric problems are symptoms of the common underlying autoimmune disease.
Second, in antibody-negative patients and in glutamic acid decarboxylase (GAD) antibody-related limbic encephalitis, seizures, structural brain alterations, cognition, and psychiatric symptoms show variations over time which seem quite independent of each other [81, 84] . Here, seizures, morphological changes, cognition and psychiatric problems again represent symptoms of some underlying disease, which should be followed-up independently with a multimodal diagnostic approach.
Third, in an epileptological context, patients with limbic encephalitis are seen because they present with acute and often late-onset temporal lobe epilepsy. Temporal lobe seizures are not a required criterion for the diagnosis of limbic encephalitis, and there is an unknown number of patients with limbic encephalitis who do not have seizures and will not consult an epilepsy center. Nevertheless, we had the chance to observe a patient prior to developing seizures and prior to the diagnosis of a GAD antibody related limbic encephalitis. This patient visited the clinic because of two amnestic episodes months before. The patient complained about anterograde as well as retrograde episodic memory problems (loss of autonoetic awareness of recent biographical memories and accelerated long-term forgetting). Over several months, the patient searched for a doctor and was diagnosed as suffering from burn-out and depression [85] . Here, the cognitive and behavioral problems preceded the epilepsy. This is consistent with the fact that the first epileptic seizure may mark the onset of epilepsy with overt seizures, but not the onset of the underlying pathological condition.
Conclusion
As outlined in the present article, there is indeed a certain bidirectional relationship between epilepsy and cognition. On the one hand seizures can have a time-limited and reversible negative impact on cognition (i.e. ictal and postictal cognitive dysfunction), and also interictal epileptic discharges may affect cognitive performance. On the other hand there are cases in which certain cognitive or behavioral activities can either elicit or prevent, suppress or abort a seizure, providing the basis for behavioral seizure control techniques.
However, seizures and cognitive deficits may also represent distinct symptoms of a common underlying brain pathology as in limbic encephalitis.
As it stands there is no convincing evidence in man that recurrent seizures or the accumulation of lifetime seizures, taken alone, lead to a progressive and irreversible decline of (previously developed) cognitive functions. The idea of a "pure" epilepsy without an underlying pathology which causes mental decline is insupportable when taking into account that even with genetic epilepsies, some kind of pathology must be present to cause seizures. In those cases in which the etiology of epilepsy is clearcut, having seizures seems to be much more symptomatic than an actual disease, and if seizures are considered symptomatic, then a search for the underlying cause must be undertaken.
Thus, we suggest a very pragmatic approach in response to the question raised in this article. A neuropsychological assessment should be conducted in order to determine: 1) to which degree cognitive and behavioral problems result from the active epilepsy or its treatment; 2) whether impairments are consistent with early vs. late acquired brain pathology; 3) whether the problems reflect developmental hindrance or accelerated mental decline with reference to the baseline conditions. If cognition or behavior are impaired or show a negative dynamic, then this, like the first seizure or the exacerbation of seizures, should alert the physician to initiate a search for the underlying cause.
For depression as one of the major comorbidities of epilepsy it has been demanded since long that it needs to be diagnosed and treated. The same should be demanded in regard to the cognitive impairments in epilepsy. For patients with epilepsy who display cognitive and behavioral problems, additional education, training, occupational therapy and/or psychotherapy should be provided. Taking the suggested bidirectional relation of epilepsy and cognition into account, we would even not exclude that training up the brain may have beneficial effects in regard to seizure control.
As long as we believe that seizures are causing all of the problems seen in epilepsy, then all of the treatment efforts will be directed towards the seizures. This assumes that all of the patient's problems would be resolved if the seizures were controlled. However, this is not the case, and just focusing on the seizures may prevent the search for any underlying, active or past disease process which, when treated, may improve the patient's overall condition, including cognitive and behavioral problems. For many years, we have speculated as to how adult patients with earlyonset temporal lobe epilepsy developed hippocampal sclerosis and an association with febrile seizures was discovered. Limbic encephalitis may provide additional answers. Seizures are the prominent problem in epilepsy, but the other symptoms can pose a severe burden as well. These symptoms must also be treated, particularly if the seizures cannot be fully controlled.
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